Abstract
Purpose
Many people travel abroad to access fertility treatments. This growing phenomenon is known as cross border reproductive care (CBRC) or fertility tourism. Due to its complex nature and implications worldwide, CBRC has become an emerging dilemma deserving more attention on the global healthcare agenda.
Methods
According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic review of the literature was performed for all relevant full-text articles published in PubMed in English during the past 18 years to explore CBRC phenomenon in the new millennium.
Results
Little is known about the accurate magnitude and scope of CBRC around the globe. In this systematic and critical review, we identify three major dimensions of CBRC: legal, economic, and ethical. We analyze each of these dimensions from clinical and practical perspectives.
Conclusion
CBRC is a growing reality worldwide with potential benefits and risks. Therefore, it is very crucial to regulate the global market of CBRC on legal, economic, and ethical bases in order to increase harmonization and reduce any forms of exploitation. Establishment of accurate international statistics and a global registry will help diminish the current information gap surrounding the CBRC phenomenon.
Similar content being viewed by others
References
Ethics Committee of the American Society for Reproductive Medicine. Cross-border reproductive care: an ethics committee opinion. Fertil Steril. 2016;106(7):1627–33.
Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE task force on ethics and law 15: cross-border reproductive care. Hum Reprod. 2008;23(10):2182–4.
Shenfield F, Pennings G, De Mouzon J, Ferraretti AP, Goossens V, ESHRE Task Force ‘Cross Border Reproductive Care’ (CBRC). ESHRE’s good practice guide for cross-border reproductive care for centers and practitioners. Hum Reprod. 2011;26(7):1625–7.
Gürtin ZB, Inhorn MC. Introduction: travelling for conception and the global assisted reproduction market. Reprod BioMed Online. 2011;23(5):535–7.
Inhorn MC, Patrizio P. Rethinking reproductive “tourism” as reproductive “exile”. Fertil Steril. 2009;92(3):904–6.
Matorras R. Reproductive exile versus reproductive tourism. Hum Reprod. 2005;20(12):3571.
Salama M. Cross border reproductive care (CBRC): a global perspective. Obstet Gynecol Int J. 2014;1(2):00008.
Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015;21(4):411–26.
Couture V, Drouin R, Tan SL, Moutquin JM, Bouffard C. Cross-border reprogenetic services. Clin Genet. 2015;87(1):1–10.
Ethics Committee of American Society for Reproductive Medicine. Cross-border reproductive care: a committee opinion. Fertil Steril. 2013;100(3):645–50.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34.
Storrow RF. Assisted reproduction on treacherous terrain: the legal hazards of cross-border reproductive travel. Reprod BioMed Online. 2011;23(5):538–45.
Van Hoof W, Pennings G. Extraterritorial laws for cross-border reproductive care: the issue of legal diversity. Eur J Health Law. 2012;19(2):187–200.
Crockin SL. Legal perspectives on cross-border reproductive care. Reprod BioMed Online. 2011;23(7):811–3.
Pennings G. Legal harmonization and reproductive tourism in Europe. Hum Reprod. 2004;19(12):2689–94.
Jackson E, Millbank J, Karpin I, Stuhmcke A. Learning from cross-border reproduction. Med Law Rev. 2017;25(1):23–46.
Millbank J. Responsive regulation of cross-border assisted reproduction. J Law Med. 2015;23(2):346–64.
Flatscher-Thöni M, Voithofer C. Should reproductive medicine be harmonized within Europe? Eur J Health Law. 2015;22(1):61–74.
Van Hoof W, Pennings G, De Sutter P. Cross-border reproductive care for law evasion: should physicians be allowed to help infertility patients evade the law of their own country? Eur J Obstet Gynecol Reprod Biol. 2016;202:101–5.
Harper J, Geraedts J, Borry P, Cornel MC, Dondorp WJ, Gianaroli L, et al. ESHG, ESHRE and EuroGentest2. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. Hum Reprod. 2014;29(8):1603–9.
Harper JC, Geraedts J, Borry P, Cornel MC, Dondorp W, Gianaroli L, et al. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. Eur J Hum Genet. 2013;21(Suppl 2):S1–21.
Crockin SL. Growing families in a shrinking world: legal and ethical challenges in cross-border surrogacy. Reprod BioMed Online. 2013;27(6):733–41.
International Federation of Fertility Societies. IFFS Surveillance 2016. Glob Reprod Health. 2016;1:1–143.
Rashedi AS, SFD R, Ataman LM, Edmonds ME. et al., Survey of fertility preservation options available to patients with cancer around the globe. J Glob Oncol. 2017; https://doi.org/10.1200/JGO.2016.008144.
Rashedi AS, SFD R, Ataman LM, Edmonds ME, et al. Survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe. J Glob Oncol. 2017; https://doi.org/10.1200/JGO.2017.009944.
Forman R. Cross-border reproductive care: a clinician’s perspective. Reprod BioMed Online. 2011;23(7):808–10.
Spar D. Reproductive tourism and the regulatory map. N Engl J Med. 2005;352(6):531–3.
Blyth E. Fertility patients’ experiences of cross-border reproductive care. Fertil Steril. 2010;94(1):e11–5.
Whittaker A, Speier A. “Cycling overseas”: care, commodification, and stratification in cross-border reproductive travel. Med Anthropol. 2010;29(4):363–83.
Messinis IE, Messini CI, Daponte A, Garas A, Mahmood T. The current situation of infertility services provision in Europe. Eur J Obstet Gynecol Reprod Biol. 2016.
Hertz R, Nelson MK, Suñol J. Attitudes toward regulations of reproductive care in the European Union: a comparison between travellers for cross-border reproductive care and citizens of the local country. Facts Views Vis Obgyn. 2016;8(3):147–60.
Hughes EG, Sawyer A, DeJean D, Adamson GD. Cross-border reproductive care in North America: a pilot study testing a prospective data collection program for in vitro fertilization clinics in Canada and the United States. Fertil Steril. 2016;105(3):786–90.
Levine AD, Boulet SL, Berry RM, Jamieson DJ, Alberta-Sherer HB, Kissin DM. Assessing the use of assisted reproductive technology in the United States by non-United States residents. Fertil Steril. 2017;108(5):815–21.
Rodino IS, Goedeke S, Nowoweiski S. Motivations and experiences of patients seeking cross-border reproductive care: the Australian and New Zealand context. Fertil Steril. 2014;102(5):1422–31.
Hibino Y, Shimazono Y, Kambayashi Y, Hitomi Y, Nakamura H. Attitudes towards cross-border reproductive care among infertile Japanese patients. Environ Health Prev Med. 2013;18(6):477–84.
Inhorn MC, Shrivastav P, Patrizio P. Assisted reproductive technologies and fertility “tourism”: examples from global Dubai and the Ivy League. Med Anthropol. 2012;31(3):249–65.
Shenfield F, de Mouzon J, Pennings G, et al. Cross border reproductive care in six European countries. Hum Reprod. 2010;25(6):1361–8.
European IVF-monitoring Consortium (EIM); European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, De Geyter C, Kupka MS, de Mouzon J, Erb K, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017;32(10):1957–73.
Hudson N, Culley L, Blyth E, Norton W, Pacey A, Rapport F. Cross-border-assisted reproduction: a qualitative account of UK travellers’ experiences. Hum Fertil (Camb). 2016;19(2):102–10.
Hudson N, Culley L. Assisted reproductive travel: UK patient trajectories. Reprod BioMed Online. 2011;23(5):573–81.
Van Hoof W, De Sutter P, Pennings G. “Now we feel like we did everything we could”: a qualitative study into the experiences of Dutch patients who travelled to Belgium for infertility treatment. Facts Views Vis Obgyn. 2014;6(4):185–93.
Van Hoof W, Pennings G, De Sutter P. Cross-border reproductive care for law evasion: a qualitative study into the experiences and moral perspectives of French women who go to Belgium for treatment with donor sperm. Soc Sci Med. 2015;124:391–7.
Bassan S, Michaelsen MA. Honeymoon, medical treatment or big business? An analysis of the meanings of the term “reproductive tourism” in German and Israeli public media discourses. Philos Ethics Humanit Med. 2013;8:9.
Hunt J. Cross border treatment for infertility: the counselling perspective in the UK. Hum Fertil (Camb). 2013;16(1):64–7.
Hamilton M. Sperm donation in the United Kingdom in 2010. Hum Fertil (Camb). 2010;13(4):257–62.
Flower D. Assisted reproduction: should egg and sperm donors be paid? J Fam Health Care. 2010;20(2):69–71.
Bay B, Larsen PB, Kesmodel US, Ingerslev HJ. Danish sperm donors across three decades: motivations and attitudes. Fertil Steril. 2014;101(1):252–257.e1.
Bergmann S. Reproductive agency and projects: Germans searching for egg donation in Spain and the Czech Republic. Reprod BioMed Online. 2011;23(5):600–8.
Madero S, Gameiro S, García D, Cirera D, Vassena R, Rodríguez A. Quality of life, anxiety and depression of German, Italian and French couples undergoing cross-border oocyte donation in Spain. Hum Reprod. 2017;32(9):1862–70.
Pennings G, de Mouzon J, Shenfield F, Ferraretti AP, Mardesic T, Ruiz A, et al. Socio-demographic and fertility-related characteristics and motivations of oocyte donors in eleven European countries. Hum Reprod. 2014;29(5):1076–89.
Ethics Committee of the American Society for Reproductive Medicine. Defining embryo donation: an Ethics Committee opinion. Fertil Steril. 2016;106(1):56–8.
Sreenivas K, Campo-Engelstein L. Domestic and international surrogacy laws: implications for cancer survivors. Cancer Treat Res. 2010;156:135–52.
Pande A. Transnational commercial surrogacy in India: gifts for global sisters? Reprod BioMed Online. 2011;23(5):618–25.
Saxena P, Mishra A, Malik S. Surrogacy: ethical and legal issues. Indian J Community Med. 2012;37(4):211–3.
Covington SN, Patrizio P. Gestational carriers and surrogacy. In: Sauer M, editor. Principles of oocyte and embryo donation. 2nd ed. London: Springer Verlag; 2013. p. 277–88.
Svitnev K. Legal regulation of assisted reproduction treatment in Russia. Reprod BioMed Online. 2010;20(7):892–4.
Capelouto SM, Archer SR, Morris JR, Kawwass JF, Hipp HS. Sex selection for non-medical indications: a survey of current pre-implantation genetic screening practices among U.S. ART clinics. J Assist Reprod Genet. 2017; https://doi.org/10.1007/s10815-017-1076-2.
Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100(5):1214–23.
Woodruff TK. Oncofertility: a grand collaboration between reproductive medicine and oncology. Reproduction. 2015;150(3):S1–10.
Salama M, Winkler K, Murach KF, Seeber B, Ziehr SC, Wildt L. Female fertility loss and preservation: threats and opportunities. Ann Oncol. 2013;24(3):598–608.
Petropanagos A, Cattapan A, Baylis F, Leader A. Social egg freezing: risk, benefits and other considerations. CMAJ. 2015;187(9):666–9.
ESHRE Task Force on Ethics and Law, Dondorp W, de Wert G, Pennings G, Shenfield F, Devroey P, et al. Oocyte cryopreservation for age-related fertility loss. Hum Reprod. 2012;27(5):1231–7.
Rebar RW. Social and ethical implications of fertility preservation. Fertil Steril. 2016;105(6):1449–51.
Bower B, Quinn GP. Fertility preservation in cancer patients: ethical considerations. Adv Exp Med Biol. 2012;732:187–96.
Garceau L, Henderson J, Davis LJ, Petrou S, Henderson LR, McVeigh E, et al. Economic implications of assisted reproductive techniques: a systematic review. Hum Reprod. 2002;17(12):3090–109.
Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod Update. 2002;8(3):265–77.
Connolly MP, Ledger W, Postma MJ. Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms. Hum Fertil (Camb). 2010;13(1):13–8.
Chambers GM, Sullivan E. a, Ishihara O et al. The economic impact of assisted reproductive technology: a review of selected developed countries. Fertil Steril. 2009;91(6):2281–94.
Connolly MP, Hoorens S, Chambers GM. The costs and consequences of assisted reproductive technology: an economic perspective. Hum Reprod Update. 2010;16(6):603–13.
Connolly M. Cross-border reproductive care: market forces in action or market failure? An economic perspective. Reprod BioMed Online. 2011;23(7):817–9.
McKelvey A, David AL, Shenfield F, Jauniaux ER. The impact of cross-border reproductive care or ‘fertility tourism’ on NHS maternity services. BJOG. 2009;116(11):1520–3.
Austin CR. Legal, ethical and historical aspects of assisted human reproduction. Int J Dev Biol. 1997;41(2):263–5.
Shanner L, Nisker J. Bioethics for clinicians: 26. Assisted reproductive technologies. CMAJ. 2001;164(11):1589–94.
Brezina PR, Zhao Y. The ethical, legal, and social issues impacted by modern assisted reproductive technologies. Obstet Gynecol Int. 2012;2012:686253.
Frydman PR. Human reproduction: possibilities and ethical borders. Folia Histochem Cytobiol. 2009;47(5):S5–7.
Baši M, Milojevi M, Miti D, Cvetkovi J. Ethical aspects in the area of assisted reproduction 2010; 27(3):171–178.
Inhorn MC. Cosmopolitan conceptions: IVF sojourns in Global Dubai. Durham: Duke University Press; 2015.
Ferraretti AP, Pennings G, Gianaroli L, Natali F, Magli MC. Cross-border reproductive care: a phenomenon expressing the controversial aspects of reproductive technologies. Reprod BioMed Online. 2010;20(2):261–6.
Crozier GKD, Martin D. How to address the ethics of reproductive travel to developing countries: a comparison of national self-sufficiency and regulated market approaches. Dev World Bioeth. 2012;12(1):45–54.
Deonandan R, Green S, van Beinum A. Ethical concerns for maternal surrogacy and reproductive tourism. J Med Ethics. 2012;38(12):742–5.
Blyth E, Thorn P, Wischmann T. CBRC and psychosocial counselling: assessing needs and developing an ethical framework for practice. Reprod BioMed Online. 2011;23(5):642–51.
Shalev C, Moreno A, Eyal H, Leibel M, Schuz R, Eldar-Geva T. Ethics and regulation of inter-country medically assisted reproduction: a call for action. Isr J Health Policy Res. 2016;5:59. eCollection 2016
Deonandan R. Recent trends in reproductive tourism and international surrogacy: ethical considerations and challenges for policy. Risk Manag Health Policy. 2015;8:111–9.
Hammarberg K, Stafford-Bell M, Everingham S. Intended parents’ motivations and information and support needs when seeking extraterritorial compensated surrogacy. Reprod BioMed Online. 2015;31(5):689–96.
Gossett DR, Nayak S, Bhatt S, Bailey SC. What do healthy women know about the consequences of delayed childbearing? J Health Commun. 2013;18(Suppl 1):118–28.
Miura LN, Boxer RS. Women in medicine and the ticking clock. Ann Fam Med. 2013;11(4):381–2.
Mac Dougall K, Beyene Y, Nachtigall RD. Age shock: misperceptions of the impact of age on fertility before and after IVF in women who conceived after age 40. Hum Reprod. 2013;28(2):350–6.
Wiebe E, Chalmers A, Yager H. Delayed motherhood: understanding the experiences of women older than age 33 who are having abortions but plan to become mothers later. Can Fam Physician. 2012;58(10):e588–95.
Corbett SL, Frecker HM, Shapiro HM, Yudin MH. Access to fertility services for lesbian women in Canada. Fertil Steril. 2013;100(4):1077–80.
The Ethics Committee of the American Society for Reproductive Medicine. Access to fertility treatment by gays, lesbians, and unmarried persons. Fertil Steril. 2009;92(4):1190–3.
The Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced age: a committee opinion. Fertil Steril. 2013;100(2):337–40.
Vincent-Rohfritsch A, Marszalek A, Santulli P, Gayet V, Chapron C, Goffinet F, et al. Risk of perinatal complication and egg donation: role of resorting to cross-border care? J Gynecol Obstet Biol Reprod (Paris). 2016;45(8):866–75.
Ahuja KK. Patient pressure: is the tide of cross-border reproductive care beginning to turn? Reprod BioMed Online. 2015;30(5):447–50.
Casey V, Crooks V. a, Snyder J, Turner L. Knowledge brokers, companions, and navigators: a qualitative examination of informal caregivers’ roles in medical tourism. Int J Equity Health. 2013;12:94.
Speier AR. Brokers, consumers and the internet: how North American consumers navigate their infertility journeys. Reprod BioMed Online. 2011;23(5):592–9.
Ikemoto LC. Reproductive tourism: equality concerns in the global market for fertility services. Law Ineq. 2009;27:277–309.
Swink DR, Reich B. Outsourcing reproduction : embryos and surrogacy services in the cyberprocreation era. J Health Care Law Policy. 2011;14:241–97.
Penney K, Snyder J, Crooks VA, Johnston R. Risk communication and informed consent in the medical tourism industry: a thematic content analysis of Canadian broker websites. BMC Med Ethics. 2011;12:17.
Burry KA. Reproductive medicine: where we have been, where we are, where are we going? An ethical perspective. Am J Obstet Gynecol. 2007;196:578–80.
Donchin A. Reproductive tourism and the quest for global gender justice. Bioethics. 2010;24(7):323–32.
Schäfer D, Baumann R, Kettner M. Ethics and reproductive medicine. Hum Reprod Update. 1996;2(5):447–56.
Armour KL. An overview of surrogacy around the world: trends, questions and ethical issues. Nurs Womens Health. 2012;16:231–6.
Neri M, Turillazzi E, Pascale N, Riezzo I, Pomara C. Egg production and donation: a new frontier in the global landscape of cross-border reproductive care: ethical concerns. Curr Pharm Biotechnol. 2016;17(4):316–20.
Norton W, Crawshaw M, Hudson N, Culley L, Law C. A survey of UK fertility clinics’ approach to surrogacy arrangements. Reprod BioMed Online. 2015;31(3):327–38.
Janssens PM, Thorn P, Castilla JA, Frith L, Crawshaw M, Mochtar M, et al. Evolving minimum standards in responsible international sperm donor offspring quota. Reprod BioMed Online. 2015;30(6):568–80.
The Ethics Committee of the American Society for Reproductive Medicine. Consideration of the gestational carrier: a committee opinion. Fertil Steril. 2013;99(7):1838–41.
Loike JD, Fischbach RL. New ethical horizons in gestational surrogacy. J IVF Reprod Med Genet. 2013;1:109.
Brinsden PR. Gestational surrogacy. Hum Reprod Update. 2003;9:483–91.
Qadeer I. Social and ethical basis of legislation on surrogacy: need for debate. Indian J Med Ethics. 2009;6(1):28–31.
Ergas Y. Babies without borders: human rights, human dignity and the regulation of international commercial surrogacy. Emory Int Law Rev. 2013:1–69.
Melo-Martín ID. The ethics of anonymous gamete donation: is there a right to know one’s genetic origins? Hast Cent Rep. 2014;44(2):28–35.
Ethics Committee of the American Society for Reproductive Medicine. Use of reproductive technology for sex selection for nonmedical reasons. Fertil Steril. 2015;103(6):1418–22.
Patrizio P, Caplan AL. Ethical issues surrounding fertility preservation in cancer patients. Clin Obstet Gynecol. 2010;53(4):717–26.
Cohen CB. Ethical issues regarding fertility preservation in adolescents and children. Pediatr Blood Cancer. 2009;53(2):249–53.
The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100(5):1224–31.
Schenker JG. Assisted reproduction practice: religious perspectives. Reprod BioMed Online. 2005;10(3):310–9.
Nikiforova B. Theological discourse in bioethics: general and confessional differences. Santalka Filosofija. 2006;14(1):62–76.
Sureau C. From transgression to pragmatism in reproductive medicine. Reprod Nutr Dev. 2005;45(3):307–19.
Fasouliotis SJ, Schenker JG. Social aspects in assisted reproduction. Hum Reprod Update. 1999;5(1):26–39.
Schenker JG. Gender selection: cultural and religious perspectives. J Assist Reprod Genet. 2002;19(9):400–10.
Lanzone A. Ethical issues in human reproduction: catholic perspectives. Gynecol Endocrinol. 2013;29(11):953–4.
Serour GI, Dickens BM. Assisted reproduction developments in the Islamic world. Int J Gynaecol Obstet. 2001;74(2):187–93.
Serour GI. Ethical issues in human reproduction: Islamic perspectives. Gynecol Endocrinol. 2013;29(11):949–52.
Schenker JG. Human reproduction: Jewish perspectives. Gynecol Endocrinol. 2013;29(11):945–8.
Markwell HJ, Brown BF. Bioethics for clinicians: 27. Catholic bioethics CMAJ. 2001;165(2):189–92.
Serour GI, Aboulghar MA, Mansour RT. Bioethics in medically assisted conception in the Muslim world. J Assist Reprod Genet. 1995;12(9):559–65.
Schenker JG. Assisted reproductive technology: perspectives in Halakha (Jewish religious law). Reprod BioMed Online. 2008;17(Suppl 3):17–24.
Inhorn MC. The new Arab man: emergent masculinities, technologies, and Islam in the Middle East. Princeton, NJ: Princeton University Press; 2012.
Inhorn MC. Local babies, global science: gender, religion, and in vitro fertilization in Egypt. New York: Routledge; 2003.
Inhorn MC, Patrizio P. The global landscape of cross-border reproductive care: twenty key findings for the new millennium. Curr Opin Obstet Gynecol. 2012;24(3):158–63.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflicts of interest.
Rights and permissions
About this article
Cite this article
Salama, M., Isachenko, V., Isachenko, E. et al. Cross border reproductive care (CBRC): a growing global phenomenon with multidimensional implications (a systematic and critical review). J Assist Reprod Genet 35, 1277–1288 (2018). https://doi.org/10.1007/s10815-018-1181-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-018-1181-x